Abstract: The present invention provides a method and apparatus for a wine bottle packaging divider and display. The method and apparatus comprise of a divider with opposing side edges and opposing top and bottom edges. The divider has a partitioning line dividing the divider into a first section and a second section, wherein at least one of the first section and the second section is capable of displaying an advertisement. The divider also has at least one pair of elongated openings, wherein each of the at least one pair of elongated openings has an end in proximity to one of the opposing top and bottom edges, wherein said at least one pair of elongated openings is capable of being opened to the one edge and slidably coupled onto a vertical wall for displaying the advertisement. The divider is folded along the partitioning line to fit within a container for packaging the glass bottles.

Abstract: The present invention provides a method and apparatus for a wine bottle packaging divider and display. The method and apparatus comprise of a divider with opposing side edges and opposing top and bottom edges. The divider has a partitioning line dividing the divider into a first section and a second section, wherein at least one of the first section and the second section is capable of displaying an advertisement. The divider also has at least one pair of elongated openings, wherein each of the at least one pair of elongated openings has an end in proximity to one of the opposing top and bottom edges, wherein said at least one pair of elongated openings is capable of being opened to the one edge and slidably coupled onto a vertical wall for displaying the advertisement. The divider is folded along the partitioning line to fit within a container for packaging the glass bottles.

Abstract: Methods, compositions and kits for modulating demethylation in a mammalian cell are provided. Also provided are methods, compositions and kits for screening candidate agents for activity in modulating genomic DNA demethylation in mammalian cells. These methods, compositions and kits find use in producing induced pluripotent stem cells (iPS) and somatic cells in vitro and for treating human disorders including cancer and disorders arising from defects in genomic imprinting.